
Overview
Jaclyn Tilak is an associate in the Dispute Resolution Group at Goodmans. Her practice focuses on commercial litigation, with an emphasis on intellectual property disputes.
Jaclyn has been counsel on a number of cases involving the Patented Medicines (Notice of Compliance) Regulations, and patent validity and infringement. Jaclyn has appeared before the Federal Court and the Federal Court of Appeal.
Jaclyn is recognized as an Associate to Watch in the area of Intellectual Property: Litigation by Chambers Canada. She is also recognized as a Rising Star in IP by The Legal 500 Canada and IP Stars.
Expertise
-
Communications and Media
-
Corporate and Commercial Litigation
-
Dispute Resolution
-
Food and Drug Regulatory and Litigation
-
Health and Pharmaceutical Litigation
-
Intellectual Property
-
Patent Prosecution, Licensing and Transactions
-
Patent, Trademark and Copyright Litigation
-
PMPRB Strategies and Litigation
-
Real Estate Brokerage Compliance
-
Regulatory, Administrative and Public Law
-
Technology
-
Technology Disputes
-
Trademark Prosecution, Licensing and Transactions
Featured Work
Jaclyn’s representative work includes acting for:
- AbbVie Corporation v. JAMP Pharma Corporation, 2022 FC 1209 – successful representation of JAMP in a judicial review application resulting in JAMP retaining its Notice of Compliance for its adalimumab product
- Steelhead v. ARC Resources, 2022 FC 998 – successful representation of four defendants in a summary trial dismissing an action for alleged patent infringement
- Teva Canada Innovation v. Pharmascience, 2020 FC 1158 – successful challenge to the validity of a patent related to a multiple sclerosis medication, on the basis of obviousness
- Eli Lilly v. Apotex, 2020 FC 816 – successful challenge to the validity and infringement of a patent relating to the dose of an ED medication, on the bases of anticipation and obviousness
- Eli Lilly v. Apotex, 2020 FC 814 – successful challenge to the validity and infringement of a patent relating to the process to make the active ingredient in an ED medication, on the bases of anticipation and obviousness
- Evolution Technologies v. Human Care Canada, 2019 FCA 209 – successful appeal of a trial judgment enjoining the sale of a major mobility-aid product and awarding financial remedies on account of patent infringement
- Evolution Technologies v. Human Care Canada, 2019 FCA 11 – successful motion to stay a trial judgment enjoining the sale of a major mobility-aid product and awarding financial remedies, pending the outcome of an appeal
Awards & Recognition
-
Chambers Canada Associates to Watch, Intellectual Property: Litigation 2023
-
The Legal 500 Canada Rising Star, Intellectual Property 2023
-
The Legal 500 Canada Rising Star, Intellectual Property 2022
-
IP Stars Rising Star 2022
-
The Legal 500 Canada Rising Star, Intellectual Property 2021
-
IP Stars Rising Star 2021
Credentials
Professional Involvement
Jaclyn is an active member of the community and volunteers with Pro Bono Ontario, providing summary legal advice to Ontarians in need.
Credentials
- Western University, J.D., 2016
- Queen's University, B.Sc., 2013, Chemical Engineering, First Class Honours
Professional Affiliations
- Law Society of Ontario
- The Advocates’ Society
- Toronto Intellectual Property Group
Call to Bar
- 2017 Ontario
Insights
-
Intellectual Property
Minister of Health’s Decision that JAMP is not a “Second Person” Was Reasonable
In its new drug submission for SIMLANDI, a biosimilar containing adalimumab, JAMP Pharma Corporation (“JAMP”) sought approval for three specific presentations: (i) 40 mg/0.4 mL pre-filled syringe… -
Intellectual Property
US Chief Justice Supports the Plan to Review Patent Trial Forum-shopping
As reported by Bloomberg News, the Chief Justice of the Supreme Court of the United States, John Roberts, has supported the call for the federal courts’ policy-making body to review rules that have… -
Intellectual Property
Spotify Snuffs Out Cannabis Company’s Trademark Claim
To put it bluntly, Potify is too similar to Spotify. That was what the Trademark Trial and Appeal Board held when it refused to register the trademark Potify as an app for cannabis… -
Intellectual Property
IBM Continues to Lead in Number of U.S Patents Awarded Annually
As reported by NASDAQ, for the 29th consecutive year, IBM has been awarded the highest number of patents in the U.S., according to data released by the IFI Claims Patent Service. Despite a… -
Intellectual Property
Yeezy and Gap Face Challenges with Trademark Application
As reported by The Fashion Law, the U.S. Patent and Trademark Office (“USPTO”) has issued a preliminary refusal for the Gap and Yeezy LLC’s trademark application related to the Yeezy Gap… -
Intellectual Property
DIALOG Files Patent Application for Hybrid Timber Floor System
As reported by Remi Network, DIALOG has filed a patent application for its Hybrid Timber Floor System (“HTFS”) in Canada, the United States, the European Union, Australia and China. The HTFS is…
News & Events
-
Banking and Financial Services
The Legal 500 Canada Continues to Recognize Goodmans with Top Tier Rankings
We are pleased to announce Goodmans LLP has once again received top tier recognition from The Legal 500 Canada in their 2023 Guide released today. Recognition from The Legal 500 is based on… -
Mergers and Acquisitions
Chambers and Partners Continues to Honour Goodmans with Top Tier Recognition
We are delighted to announce Goodmans LLP has once again received top tier recognition from Chambers and Partners in the Chambers Canada 2023 Guide released today. Recognition from Chambers…